IMMUNOLOGICAL STUDY OF HUMAN RECOMBINANT INTERLEUKIN-2 (LOW-DOSE) IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA

被引：25
|
作者：
MARUMO, K [1 ]
MURAKI, J [1 ]
UENO, M [1 ]
TACHIBANA, M [1 ]
DEGUCHI, N [1 ]
BABA, S [1 ]
JITSUKAWA, S [1 ]
HATA, M [1 ]
TAZAKI, H [1 ]
机构：
[1] KEIO UNIV,SCH MED,DEPT UROL,TOKYO 108,JAPAN
来源：
UROLOGY | 1989年 / 33卷 / 03期
关键词：
D O I：
10.1016/0090-4295(89)90396-8
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：219 / 225
页数：7
相关论文
共 50 条
  • [1] IMMUNOLOGICAL STUDY OF HUMAN RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA
    MARUMO, K
    MURAKI, J
    UENO, M
    DEGUCHI, N
    BABA, S
    TAZAKI, H
    JOURNAL OF UROLOGY, 1987, 137 (04): : A146 - A146
  • [2] LOW-DOSE INTERLEUKIN-2 IN THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA
    STADLER, WM
    VOGELZANG, NJ
    SEMINARS IN ONCOLOGY, 1995, 22 (01) : 67 - 73
  • [3] SUBCUTANEOUS LOW-DOSE RECOMBINANT INTERLEUKIN-2 AND ALPHA-INTERFERON IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
    RAVAUD, A
    NEGRIER, S
    CANY, L
    MERROUCHE, Y
    LEGUILLOU, M
    BLAY, JY
    CLAVEL, M
    GASTON, R
    OSKAM, R
    PHILIP, T
    BRITISH JOURNAL OF CANCER, 1994, 69 (06) : 1111 - 1114
  • [4] A PHASE-II STUDY OF LOW-DOSE CYCLOPHOSPHAMIDE AND RECOMBINANT HUMAN INTERLEUKIN-2 IN METASTATIC RENAL-CELL CARCINOMA AND MALIGNANT-MELANOMA
    LINDEMANN, A
    HOFFKEN, K
    SCHMIDT, RE
    DIEHL, V
    KLOKE, O
    GAMM, H
    HAYUNGS, J
    OSTER, W
    BOHM, M
    KOLITZ, JE
    FRANKS, CR
    HERRMANN, F
    MERTELSMANN, RH
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1989, 28 (04) : 275 - 281
  • [5] LOW-DOSE CYCLOPHOSPHAMIDE, ALPHA-INTERFERON AND CONTINUOUS INFUSIONS OF INTERLEUKIN-2 IN ADVANCED RENAL-CELL CARCINOMA
    WERSALL, JP
    MASUCCI, G
    HJELM, AL
    RAGNHAMMAR, P
    FAGERBERG, J
    FRODIN, JE
    MERK, K
    LINDEMALM, C
    ERICSON, K
    KALIN, B
    MELLSTEDT, H
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1993, 10 (03): : 103 - 111
  • [6] MALIGNANT-MELANOMA AND RENAL-CELL CARCINOMA - IMMUNOLOGICAL AND HEMATOLOGICAL EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN-2
    HAYAT, K
    RODGERS, S
    BRUCE, L
    REES, RC
    CHAPMAN, K
    REEDER, S
    DORREEN, MS
    SHERIDAN, E
    SREENIVASAN, T
    HANCOCK, BW
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (08) : 1009 - 1014
  • [7] PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA TREATED WITH RECOMBINANT INTERLEUKIN-2
    PALMER, PA
    VINKE, J
    PHILIP, T
    NEGRIER, S
    ATZOPODIEN, J
    KIRCHNER, H
    OSKAM, R
    FRANKS, CR
    ANNALS OF ONCOLOGY, 1992, 3 (06) : 475 - 480
  • [8] A phase II study of interferon α and low-dose subcutaneous interleukin-2 in advanced renal cell carcinoma
    A. Piga
    Paolo Giordani
    Agata Quattrone
    Marco Giulioni
    Giorgio De Signoribus
    Stefania Antognoli
    Riccardo Cellerino
    Cancer Immunology, Immunotherapy, 1997, 44 : 348 - 351
  • [9] LACK OF EFFICACY OF LOW-DOSE SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 AND INTERFERON-ALPHA IN THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA
    THIOUNN, N
    MATHIOT, C
    DORVAL, T
    FLAM, TA
    TARTOUR, E
    MOSSERI, V
    ZERBIB, M
    FRIDMAN, WH
    DEBRE, B
    BRITISH JOURNAL OF UROLOGY, 1995, 75 (05): : 586 - 589
  • [10] PHASE-II STUDY OF INTERMITTENT CONTINUOUS-INFUSION OF LOW-DOSE RECOMBINANT INTERLEUKIN-2 IN ADVANCED MELANOMA AND RENAL-CELL CANCER
    VLASVELD, LT
    HORENBLAS, S
    HEKMAN, A
    HILTON, AM
    DUBBELMAN, AC
    MELIEF, CJM
    RANKIN, EM
    ANNALS OF ONCOLOGY, 1994, 5 (02) : 179 - 181
12345